Iomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).
VHA Connecticut, West Haven, Connecticut, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.